Topamax

[Topiramate]

Patient Info
Information for Patients

Patients taking TOPAMAX ® should be told to seek immediate medical attention if they experience blurred vision or periorbital pain. Patients, especially pediatric patients, treated with TOPAMAX ® should be monitored closely for evidence of decreased sweating and increased body temperature, especially in hot weather.

Patients, particularly those with predisposing factors, should be instructed to maintain an adequate fluid intake in order to minimize the risk of renal stone formation [see PRECAUTIONS: General, for support regarding hydration as a preventative measure]. Patients should be warned about the potential for somnolence, dizziness, confusion, and difficulty concentrating and advised not to drive or operate machinery until they have gained sufficient experience on topiramate to gauge whether it adversely affects their mental and/ or motor performance.

Text Continues Below

---

Additional food intake may be considered if the patient is losing weight while on this medication. Please refer to the end of the product labeling for important information on how to take TOPAMAX ® (topiramate capsules) Sprinkle Capsules.

Laboratory Tests

Measurement of baseline and periodic serum bicarbonate during topiramate treatment is recommended (see WARNINGS).

HOW TO TAKE TOPAMAX ® (topiramate capsules)

SPRINKLE CAPSULES A Guide for Patients and Their Caregivers

Your doctor has given you a prescription for TOPAMAX ® (topiramate capsules) Sprinkle Capsules.

Here are your instructions for taking this medication. Please read these instructions prior to use.

To Take Without Food
TOPAMAX ® Sprinkle Capsules may also be swallowed as whole capsules.

For more information about TOPAMAX ® Sprinkle Capsules, ask your doctor or pharmacist.

OMP DIVISION ORTHO-McNEIL PHARMACEUTICAL, INC.
Raritan, NJ 08869 © OMP 1999 Revision Date December 2003 7517109

Page:  1 | 2 | Next >>